Bioceres Crop Solutions Corp.
For the period ended May 12, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
May 12, 2026 · Filed May 12, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Operating Expenses
Operating Expenses
**Selling, General and Administrative Expenses:**SG&A expenses totaled $16.1 million, a 16% decline compared to $19.2 million in the same quarter last year. The decrease reflects the continued execution of cost management initiatives and organizational streamlining initiatives across the continuing operations, including tighter control over discretionary spending and ongoing efficiency measures implemented over the last several quarters. Both fixed and variable expenses declined during the quarter.
D&A, share-based incentives and transactional expenses jointly amounted to $1.4 million compared to $2.3 million last year.
**Research and Development:**total R&D expenses were $1.9 million in 3Q26, compared to $2.2 million in 3Q25. D&A and share-based incentives in R&D expenses were $1.2 million and $0.9 million, respectively.
| 5 | BIOCERES CROP SOLUTIONS | THIRD QUARTER 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.